MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Cancer

• Publication date

  2011-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.25962PMID 21618216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines

  2010cited by this paper
• Structure and activity of putative intronic miRNA promoters.

  2010cited by this paper
• miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA

  2009cited by this paper
• MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

  2009cited by this paper
• miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

  2009cited by this paper
• Estrogen Regulation of MicroRNA Expression

  2009cited by this paper
• Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer.

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

  2008cited by this paper
• Role of microRNAs in drug-resistant ovarian cancer cells.

  2008cited by this paper
• Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene

  2008cited by this paper
• MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer*

  2008cited by this paper
• MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

  2007cited by this paper
• BRCA1 dysfunction in sporadic basal-like breast cancer

  2007cited by this paper
• Competing Interactions between Micro-RNAs Determine Neural Progenitor Survival and Proliferation after Ethanol Exposure: Evidence from an Ex Vivo Model of the Fetal Cerebral Cortical Neuroepithelium

  2007cited by this paper
• The let-7 microRNA represses cell proliferation pathways in human cells.

  2007cited by this paper
• The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell Lines

  2007cited by this paper
• microRNA functions.

  2007cited by this paper
• Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.

  2007cited by this paper
• The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.

  2007cited by this paper
• Tumoral expression of BRCA1, Estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.

  2006cited by this paper
• Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

  2005cited by this paper
• Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.

  2005cited by this paper
• Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas.

  2003cited by this paper
• Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.

  2001cited by this paper
• Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.

  2000cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.

  1997cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Proportion of breast cancer cases in the United States explained by well-established risk factors.

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.

  1994cited by this paper
• Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.

  1990cited by this paper

• Predicting temozolomide response in low-grade glioma patients with large-scale machine learning

  2025cites this paper
• The Critical Role of Inhibitor of Differentiation 4 in Breast Cancer: From Mammary Gland Development to Tumor Progression

  2025cites this paper
• Lipoic acid alters the microRNA signature in breast cancer cells.

  2024cites this paper
• miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine

  2024cites this paper
• Distinctive Expression of Metastamirs in Breast Cancer Mesenchymal Stem Cells Isolated from Solid Tumor.

  2024cites this paper
• Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies

  2024cites this paper
• Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis

  2024cites this paper
• Interference of the Circular RNA Sperm Antigen With Calponin Homology and Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of Breast Cancer Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway.

  2023cites this paper
• Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review

  2023cites this paper
• miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy

  2023influential citation
• Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment

  2023cites this paper
• miR-335-5p regulates the proliferation, migration and phenotypic switching of vascular smooth muscle cells in aortic dissection by directly regulating SP1

  2022cites this paper
• CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis

  2022cites this paper
• Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach.

  2022cites this paper
• Potential utility of miRNAs for liquid biopsy in breast cancer

  2022cites this paper
• Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients

  2022cites this paper
• Circulating miRNAs in Breast Cancer Diagnosis and Prognosis

  2022cites this paper
• Non-coding genome in small cell lung cancer between theoretical view and clinical applications.

  2022cites this paper
• Interactions between miRNAs and Double-Strand Breaks DNA Repair Genes, Pursuing a Fine-Tuning of Repair

  2022cites this paper
• Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.

  2022cites this paper
• Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers

  2021cites this paper
• MicroRNA-335 inhibits the growth, chemo-sensitivity, and metastasis of human breast cancer cells by targeting MAP3K2.

  2021cites this paper
• Functions and Targets of miR-335 in Cancer

  2021cites this paper
• Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments

  2021cites this paper
• OTT_A_305098 3335..3349

  2021cites this paper
• miRNAs: Critical mediators of breast cancer metastatic programming.

  2021cites this paper
• MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia

  2021cites this paper
• Linc-ROR has a Potential ceRNA Activity for OCT4A by Sequestering miR-335-5p in the HEK293T Cell Line

  2021cites this paper
• Identification of a six‐microRNA signature as a potential diagnostic biomarker in breast cancer tissues

  2021cites this paper
• Expression of MiR-335 and its target metalloproteinase genes: clinical significance in breast cancer

  2020cites this paper
• The Role of MicroRNAs in the Progression, Prognostication, and Treatment of Breast Cancer

  2020cites this paper
• MicroRNAs, DNA damage response and ageing

  2020cites this paper
• MiR-335-5p inhibits β-Amyloid (Aβ) accumulation to attenuate cognitive deficits through targeting c-jun-N-terminal kinase 3 in alzheimer's disease.

  2020cites this paper
• Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers

  2020cites this paper
• Circular RNA 0007255 regulates the progression of breast cancer through miR‐335‐5p/SIX2 axis

  2020cites this paper
• MEK/ERK pathway to regulate the proliferation and metastasis of colon cancer

  2020cites this paper
• MicroRNA-335 targets the MEK/ERK pathway to regulate the proliferation and metastasis of colon cancer.

  2020cites this paper
• Network characteristics of human RNA-RNA interactions and application in the discovery of breast cancer-associated RNAs

  2020cites this paper
• Regulation of breast cancer metastasis signaling by miRNAs

  2020cites this paper
• MicroRNA-335 inhibits the growth, chemo-sensitivity, and metastasis of human breast cancer cells by targeting MAP3K2.

  2020cites this paper
• Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level

  2020cites this paper
• LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR

  2020cites this paper
• Overexpressing miR-335 inhibits DU145 cell proliferation by targeting early growth response 3 in prostate cancer

  2019influential citation
• Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer.

  2019cites this paper
• Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer

  2019cites this paper
• LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p

  2019cites this paper
• Identification and functional characterization of microRNAs in rat Leydig cells during development from the progenitor to the adult stage

  2019cites this paper
• MicroRNA-335/ID4 dysregulation predicts clinical outcome and facilitates leukemogenesis by activating PI3K/Akt signaling pathway in acute myeloid leukemia

  2019cites this paper
• miR‐516a‐3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway

  2019cites this paper
• Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma

  2019cites this paper
• Current Smoking is Associated with Decreased Expression of miR-335-5p in Parenchymal Lung Fibroblasts

  2019cites this paper
• Epigenetic silencing of microRNA-335 contributes to nasopharyngeal carcinoma metastasis.

  2019cites this paper
• Role of microRNAs in breast cancer development and their potential as biomarkers

  2018cites this paper
• Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer.

  2018cites this paper
• The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas

  2018cites this paper
• Post-Transcriptional Control of RNA Expression in Cancer

  2018cites this paper
• MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4

  2018cites this paper
• Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer

  2018cites this paper
• The 3’-UTR of IGF1R as an ancient long noncoding RNA

  2018cites this paper
• miR-484 Functions as an Onco-miR in Triple Negative Breast Cancer

  2018cites this paper
• miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis.

  2018cites this paper
• miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a

  2018cites this paper
• An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer

  2018cites this paper
• Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo

  2018cites this paper
• Clinical aspects of circulating miRNA‐335 in breast cancer patients: A prospective study

  2018cites this paper
• Lost in translation

  2018cites this paper
• MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance

  2017cites this paper
• Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients

  2017cites this paper
• Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers

  2017cites this paper
• Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors

  2017cites this paper
• Micro RNAs and DNA methylation are regulatory players in human cells with altered X chromosome to autosome balance

  2017cites this paper
• miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1

  2017cites this paper
• CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter

  2016cites this paper
• Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation

  2016cites this paper
• microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

  2016cites this paper
• MicroRNA signature in the chemoprevention of breast cancer stem cells by Active Hexose Correlated Compound (AHCC)

  2016cites this paper
• MicroRNAs in Breast Cancer and Their Value as Biomarkers

  2016cites this paper
• ID4 Acts as a Tumor Suppressor via p53: Mechanistic Insight

  2016cites this paper
• Diverse roles of miR-335 in development and progression of cancers

  2016influential citation
• MicroRNA modulation of aldosterone production in the adrenal gland

  2016cites this paper
• MicroRNAs in Metastasis

  2016cites this paper
• Signature of microRNA expression during osteogenic differentiation of bone marrow MSCs reveals a putative role of miR-335-5p in osteoarthritis

  2015cites this paper
• microRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells.

  2015cites this paper
• A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors

  2015cites this paper
• Triple-negative breast cancer: investigating potential molecular therapeutic target

  2015cites this paper
• Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.

  2015cites this paper
• Depletion of eIF2.GTP.Met-tRNAi translation initiation complex up-regulates BRCA1 expression in vitro and in vivo

  2015cites this paper
• MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management

  2015cites this paper
• High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia

  2015cites this paper
• Mest but Not MiR-335 Affects Skeletal Muscle Growth and Regeneration

  2015cites this paper
• MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential

  2015cites this paper
• Integrative Analysis of MicroRNA and mRNA Data Reveals an Orchestrated Function of MicroRNAs in Skeletal Myocyte Differentiation in Response to TNF-α or IGF1

  2015cites this paper
• The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity

  2015cites this paper
• Bone Marrow MicroRNA-335 Level Predicts the Chemotherapy Response and Prognosis of Adult Acute Myeloid Leukemia

  2015cites this paper
• Inhibitor of differentiation 4 (ID4): From development to cancer.

  2015cites this paper
• MicroRNA-335 represents an independent prognostic marker in cervical cancer

  2015cites this paper
• Epigenomics of Breast Cancer

  2014cites this paper
• RNA Deregulation in Metastatic Breast Cancer

  2014cites this paper
• Epigenetics of BRCA-1–Related Breast Tumorigenesis and Dietary Prevention

  2014cites this paper
• Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations

  2014cites this paper